Balanced news tone
News Sentiment
BLLN sentiment intelligence
BillionToOne, Inc. Class A Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
86/100 classification confidence.
directly relevant articles
high-authority source matches
+5.3% over one week, +25.4% over four weeks, trend active, and materially above fair value.
BillionToOne CTO David Tsao sells $2.5m in company stock By Investing.com
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
BillionToOne CTO David Tsao sells $2.5m in company stock By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 20:55
- Source
- Investing.com Canada
BillionToOne SVP John ten Bosch sells $533,330 in company stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 20:50
- Source
- Investing.com
BillionToOne, Inc. (BLLN) CTO sells 20,000 shares and exercises options
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 20:38
- Source
- Stock Titan
BillionToOne, Inc. (BLLN) SVP sells 4,251 shares under Rule 10b5-1 plan
BillionToOne, Inc. SVP of Laboratory Operations, ten Bosch John Roderick, sold 4,251 shares of Class A Common Stock at $125.46 per share on July 13, 2026. The sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted in March 2026, totaling approximately $533,330
- Tone
- Negative 30/100
- Event
- Market update
- Published
- 15 Jul 2026 20:12
- Source
- Stock Titan
Qiagen stock holds steady as diagnostics demand shapes long term outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 14 Jul 2026 09:00
- Source
- Ad Hoc News
Billiontoone, Inc. $BLLN Shares Bought by Emerald Mutual Fund Advisers Trust
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 08:19
- Source
- MarketBeat
Emerald Advisers LLC Buys 50,613 Shares of Billiontoone, Inc. $BLLN
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 08:18
- Source
- MarketBeat
Billiontoone, Inc. (NASDAQ:BLLN) Given Consensus Recommendation of "Moderate Buy" by Brokerages
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jul 2026 08:18
- Source
- MarketBeat
Holder John R. Ten Bosch plans BLLN (BLLN) Class A stock sales
John R. Ten Bosch, a holder of BillionToOne, Inc. (BLLN) Class A securities, plans to sell 4,251 Class A shares through Fidelity Brokerage Services LLC on NASDAQ, with a proposed transaction date of July 13, 2026. The SEC Form 144 filing also details previous sales by Ten Bosch i
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 02:10
- Source
- Stock Titan
Insider Selling: Billiontoone (NASDAQ:BLLN) CEO Sells $1,576,250.00 in Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 21:16
- Source
- MarketBeat
Billiontoone (NASDAQ:BLLN) Insider Shan Riku Sakakibara Sells 8,000 Shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 21:14
- Source
- MarketBeat
BLLN Company (NASDAQ: BLLN) files Form 144 to sell 20,000 Class A shares
BLLN Company (NASDAQ: BLLN) has filed a Form 144 indicating an upcoming sale of up to 20,000 Class A shares, primarily related to a stock option exercise, with an estimated value of $250,497.77. The planned sale is set for July 13, 2026, on NASDAQ through Fidelity Brokerage Servi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 20:41
- Source
- Stock Titan
BillionToOne (NASDAQ: BLLN) CEO exercises options, sells 12,500 shares under 10b5-1 plan
BillionToOne, Inc. (NASDAQ: BLLN) Chairman and CEO Atay Oguzhan exercised options to acquire 12,500 shares of Class A Common Stock at $2.80 per share and subsequently sold all 12,500 shares in open-market transactions on July 9, 2026, at weighted average prices between $125.00 an
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 20:41
- Source
- Stock Titan
BillionToOne (BLLN) CPO sells 8,000 shares and exercises options in pre-set plan
BillionToOne, Inc.'s Chief Product Officer, Shan Riku Sakakibara, sold 8,000 shares of Class A Common Stock at $125.00 per share and exercised options for 4,000 shares at varying exercise prices on July 9, 2026. These transactions were carried out under a pre-arranged Rule 10b5-1
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 13 Jul 2026 20:41
- Source
- Stock Titan
[144] BillionToOne, Inc. SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 14:05
- Source
- Stock Titan
Qiagen stock holds steady as diagnostics demand supports long-term growth
- Tone
- Positive 66/100
- Event
- Macro sensitivity
- Published
- 13 Jul 2026 06:08
- Source
- Ad Hoc News
Qiagen stock reflects steady diagnostics demand as investors weigh long-term growth drivers
- Tone
- Positive 66/100
- Event
- Macro sensitivity
- Published
- 12 Jul 2026 12:19
- Source
- Ad Hoc News
Roche stock holds steady as pharma giant leans on diagnostics and oncology strength
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jul 2026 08:31
- Source
- Ad Hoc News
BLLN (NASDAQ: BLLN) File: Insider option exercise and proposed Class A resales
BillionToOne, Inc. (BLLN) has filed a Form 144 notice, indicating proposed resales of Class A shares and option exercises. The filing details an insider stock option exercise on July 9, 2026, for 12,500 shares and outlines several recent Class A share sales by named holders in Ju
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 12:40
- Source
- Stock Titan
BillionToOne (BLLN) CEO sells 38,750 shares under 10b5-1 plan
BillionToOne, Inc. (BLLN) Chairman and CEO Atay Oguzhan reported the sale of 38,750 shares of Class A Common Stock, including shares held indirectly through his spouse, under a Rule 10b5-1 trading plan. The sales occurred at weighted average prices between approximately $118 and
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 08 Jul 2026 22:39
- Source
- Stock Titan
Labcorp stock holds its business focus. Clinical diagnostics remain the core.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 09:51
- Source
- Ad Hoc News
BLLN SEC Filings - BillionToOne, Inc. 10-K, 10-Q, 8-K Forms
This page provides access to BillionToOne, Inc. (BLLN) SEC filings, including 10-K annual reports, 10-Q quarterly reports, and 8-K material event disclosures. Recent filings highlight significant ownership stakes disclosed by various investors and funds, details on IPO-related sh
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 12:10
- Source
- Stock Titan
BillionToOne (BLLN) officer sells 801 shares in Rule 10b5-1 plan
Nancy JoAnn Johnson, an officer at BillionToOne, Inc. (BLLN), sold 801 shares of Class A Common Stock for approximately $100,056 under a pre-arranged Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $124.9137, with individual transactions ranging from
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 07 Jul 2026 12:10
- Source
- Stock Titan
BLLN (NASDAQ: BLLN) insiders report proposed Class A sales
BillionToOne, Inc. (BLLN) has filed a Form 144 reporting proposed sales of Class A shares by insiders. The filing details a proposed sale of 12,500 Class A Pre-IPO shares dated May 1, 2024, and discloses recent sales in June 2026 by Ezgi N. Akcinar Atay, Oguzhan Atay, and Atay 20
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 00:11
- Source
- Stock Titan
Insiders file Rule 144 notices for Class A sales (NASDAQ: BLLN)
BillionToOne, Inc. (NASDAQ: BLLN) insiders have filed Rule 144 notices indicating planned and recent sales of Class A shares. The filing details a planned sale of 26,250 shares valued at $3,150,000.00 scheduled for July 6, 2026. Additionally, it reveals recent sales by Oguzhan At
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 00:11
- Source
- Stock Titan
BLLN (NASDAQ) insiders report Class A sales totaling 41,250 shares on 06/08/2026
BillionToOne, Inc. (BLLN) insiders reported sales of Class A shares totaling 41,250 on June 8, 2026, as per a Form 144 SEC filing. The sales included 2,500 shares by Atay 2021 Dynasty Trust for $245,562.50, 26,250 shares by Oguzhan Atay for $2,563,632.00, and 12,500 shares by Ezg
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 16:39
- Source
- Stock Titan
Labcorp stock holds steady as investors watch the next filing cycle
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 08:31
- Source
- Ad Hoc News
BillionToOne (BLLN) SVP sells 1,416 shares under Rule 10b5-1 plan
BillionToOne, Inc.'s Senior Vice President of Laboratory Operations, John Roderick ten Bosch, sold 1,416 shares of Class A Common Stock at $120.00 per share on June 29, 2026. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 6, 2026. Fo
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 02 Jul 2026 11:09
- Source
- Stock Titan
Nancy J. Johnson reports Class A sales for BLLN (NASDAQ: BLLN)
Nancy J. Johnson reported sales of Class A shares of BillionToOne, Inc. (BLLN) through two transactions in early June 2026. These sales, totaling 14,000 shares, amounted to over $1.4 million. The filing also made reference to 801 Class A pre-IPO shares acquired on July 3, 2020.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 10:39
- Source
- Stock Titan
Are Medical Stocks Lagging BillionToOne, Inc. (BLLN) This Year?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Market source